Titre:
  • SMAD4 Positive Pancreatic Ductal Adenocarcinomas Are Associated with Better Outcomes in Patients Receiving FOLFIRINOX-Based Neoadjuvant Therapy.
Auteur:Racu, Marie-Lucie; Bernardi, Dana; Chaouche, Aniss; Zindy, Egor; Navez, Julie; Loi, Patrizia; Maris, Calliope; Closset, Jean; Van Laethem, Jean-Luc; Decaestecker, Christine; Salmon, Isabelle; D'Haene, Nicky
Informations sur la publication:Cancers (Basel), 15, 15
Statut de publication:Publié, 2023-07
Sujet CREF:Médecine pathologie humaine
Anatomopathologie
Cancérologie
Mots-clés:SMAD4
biomarker
metastasis-free survival
neoadjuvant therapy
overall survival
pancreas
pancreatic ductal adenocarcinoma
prognosis
progression-free survival
Langue:Anglais
Identificateurs:urn:issn:2072-6694
info:doi/10.3390/cancers15153765
info:pii/cancers15153765
info:pmid/37568581
PMC10417261